Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs

Mergers and acquisition activity in pharmaceutical services is common, particularly between private equity-backed companies looking to add new capabilities while growing their client rosters and revenue. The latest deal has Worldwide Clinical Trials agreeing to buy Catalyst Clinical Research, a contract research organization (CRO) that brings expertise in oncology clinical studies. Financial terms of the […]